MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of MapLight Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. MapLight Therapeutics Inc. market cap is $761.05M.
What is the 52-week high for MapLight Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. MapLight Therapeutics Inc. 52 week high is $20.86 as of October 31, 2025.
What is the 52-week low for MapLight Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. MapLight Therapeutics Inc. 52 week low is $15.00 as of October 31, 2025.
What is MapLight Therapeutics Inc. stock price today?
MapLight Therapeutics Inc. stock price today is $18.37.
What was MapLight Therapeutics Inc. stock price yesterday?
MapLight Therapeutics Inc. stock price yesterday was $16.55.
What is the Price-to-Book ratio of MapLight Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. MapLight Therapeutics Inc. P/B ratio is -3.1055.
What is the 50-day moving average of MapLight Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. MapLight Therapeutics Inc. 50-day moving average is $17.40.